Chen, J., Hu, X., Li, Q., Dai, W., Cheng, X., Huang, W., . . . Yuan, G. (2020). Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients. Ann Transl Med.
Chicago ZitierstilChen, Jinzhang, et al. "Effectiveness and Safety of Toripalimab, Camrelizumab, and Sintilimab in a Real-world Cohort of Hepatitis B Virus Associated Hepatocellular Carcinoma Patients." Ann Transl Med 2020.
MLA ZitierstilChen, Jinzhang, et al. "Effectiveness and Safety of Toripalimab, Camrelizumab, and Sintilimab in a Real-world Cohort of Hepatitis B Virus Associated Hepatocellular Carcinoma Patients." Ann Transl Med 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.